Joseph Edelman, Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 136,094 shares at $30.23 ($4.1M) on 2021-08-26, disclosed to the SEC on 2021-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.23 | 68,047 | $2.1M | 50.0% |
| 2 | $30.23 | 68,047 | $2.1M | 50.0% |
| Total | $30.23 avg | 136,094 | $4.1M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |